Immunohistochemical Analysis of the Purinoceptor P2X7 in Human Lingual Nerve Neuromas

Aims: Recent evidence suggests that the purinoceptor P2X7 may be involved in the development of dysesthesia following nerve injury, therefore, the aim of the present study was to investigate whether a correlation exists between the level of P2X7 receptor expression in damaged human lingual nerves and the severity of the patients’ symptoms. Methods: Neuroma-in-continuity specimens were obtained from patients undergoing surgical repair of the damaged lingual nerve. Specimens were categorized preoperatively according to the presence or absence of dysesthesia, and visual analog scales scores were used to record the degree of pain, tingling, and discomfort. Indirect immunofluorescence using anti-bodies raised against S-100 (a Schwann cell marker) and P2X7 was employed to quantify the percentage area of S-100 positive cells that also expressed P2X7. Results: P2X7 was found to be expressed in Schwann cells of lingual nerve neuromas. No significant difference was found between the level of P2X7 expression in patients with or without symptoms of dysesthesia, and no relationship was observed between P2X7 expression and VAS scores for pain, tingling, or discomfort. No correlation was found between P2X7 expression and the time between initial injury and nerve repair. Conclusion: These data show that P2X7 is expressed in human lingual nerve neuromas from patients with and without dysesthesia. It therefore appears that the level of P2X7 expression at the injury site may not be linked to the maintenance of neuropathic pain after lingual nerve injury.

dysesthesia; immunohistochemistry; lingual nerve; nerve injury; P2X7

1. Gregg JM. Studies of traumatic neuralgia in the maxillofaial region: Symptom complexes and response to microsurgery. J Oral Maxillofac Surg 1990;48:135–140.

2. Robinson PP, Loescher AR, Smith KG. A prospective, quantitative study on the clinical outcome of lingual nerve repair. Br J Oral Maxillofac Surg 2000;38:255–263.

3. Gregg JM. Post-traumatic trigeminal neuralgia: Response to physiological, surgical and pharmacological therapies. Int Dent J 1978;28:43–51.

4. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002;82:1013–1067.

5. Collo G, Neidhart S, Kawashima E, Kosco-Vilbois M, North RA, Buell G. Tissue distribution of the P2X7 receptor. Neuropharmacology 1997;36:1277–1283.

6. Di Virgilio F, Sanz JM, Chiozzi P, Falzoni S. The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor. Prog Brain Res 1999;120:355–368.

7. Duan S, Anderson CM, Keung EC, Chen Y, Chen Y, Swanson RA. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 2003;23: 1320–1328.

8. Sperlagh B, Vizi ES, Wirkner K, Illes P. P2X7 receptors in the nervous system. Prog Neurobiol 2006;78:327–346.

9. Franke H, Gunther A, Grosche J, et al. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 2004;63:686-699.

10. Chessell IP, Hatcher JP, Bountra C, et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005;114:386–396.

11. Wang X, Arcuino G, Takano T, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004;10:821–827.

12. Dell’Antonio G, Quattrini A, Cin ED, Fulgenzi A, Ferrero ME. Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum 2002;46:3378–3385.

13. Dell’Antonio G, Quattrini A, Dal Cin E, Fulgenzi A, Ferrero ME. Antinociceptive effect of a new P(2Z)/P2X7 antagonist, oxidized ATP, in arthritic rats. Neurosci Lett 2002;327:87–90.

14. Fulgenzi A, Dell’Antonio G, Foglieni C, et al. Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP. BMC Immunol 2005;6:18.

15. Honore P, Donnelly-Roberts D, Namovic MT, et al. A- 740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4- dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 2006;319:1376–1385.

16. Vora AR, Loescher AR, Boissonade FM, Robinson PP. Ultrastructural characteristics of axons in traumatic neuromas of the human lingual nerve. J Orofac Pain 2005; 19:22–33.

17. Vora AR, Loescher AR, Craig GT, Boissonade FM, Robinson PP. A light microscopical study on the structure of traumatic neuromas of the human lingual nerve. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99:395–403.

18. Zhang XF, Han P, Faltynek CR, Jarvis MF, Shieh CC. Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia. Brain Res 2005;1052: 63–70.

19. Allgaier C, Reinhardt R, Schadlich H, et al. Somatic and axonal effects of ATP via P2X2 but not P2X7 receptors in rat thoracolumbar sympathetic neurones. J Neurochem 2004;90:359–367.

20. Perregaux D, Gabel CA. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994;269:15195–15203.

21. Ferrari D, Pizzirani C, Adinolfi E, et al. P2X7 receptor: A key player in IL-1 processing and release. J Immunol 2006;176:3877–3883.

22. Solle M, Labasi J, Perregaux DG, et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001;276:125–132.

23. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumour necrosis factor alpha. Br J Pharmacol 1997;121:417–424.

24. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471–475.

25. Labasi JM, Petrushova N, Donovan C, et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002;168: 6436–6445.

26. McGaraughty S, Chu KL, Namovic MT, Donnelly-Roberts DL, Harris RR, Zhang XF. P2X(7)-related modulation of pathological nociception in rats. Neuroscience 2007;146:1817–1828.

27. Berkley KJ. Sex differences in pain. Behav Brain Sci 1997;20:371–380.

28. Robinson PP, Loescher AR, Yates JM, Smith KG. Current management of damage to the inferior alveolar and lingual nerves as a result of removal of third molars. Br J Oral Maxillofac Surg 2004;42:285–292.

29. Gibson SJ, Farrell M. A review of age differences in the neurophysiology of nociception and the perceptual experience of pain. Clin J Pain 2004;20:227–239.